Header Logo

Connection

Mahzad Akbarpour to Antibodies, Bispecific

Back to Details
This is a "connection" page, showing publications Mahzad Akbarpour has written about Antibodies, Bispecific.
Mahzad Akbarpour
Connection Strength
0.218
Antibodies, Bispecific
  1. Bispecific antibodies targeting CTLA-4: game-changer troopers in cancer immunotherapy. Front Immunol. 2023; 14:1155778.
    View in: PubMed
    Score: 0.218
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.